Upwork stock jumps nearly 20% after freelance platform swings to adjusted Q2 profit, revenue rises 7%
Shares of Upwork Inc. (UPWK) rallied nearly 20% in the aftermarket Wednesday after the platform for freelancers narrowed its quarterly loss, swinging to an adjusted profit, and reported revenue above Wall Street expectations. Upwork lost $4 million, or 3 cents a share, in the second quarter, compared with a loss of $23.8 million, or 18 cents a share, in the second quarter of 2022. Adjusted for one-time items, the company earned 10 cents a share. Revenue grew 7% to $168.6 million, Upwork said. Analysts polled by FactSet expected Upwork to break even on an adjusted basis and to report revenue of $163 million. "Our confidence in the long-term growth opportunity for Upwork is unwavering," Upwork executives said in a letter to shareholders accompanying results. "Our continued focus as a management team is on innovation, cost discipline, and identifying the highest [return-on-investment] to generate profitable growth and shareholder value." Shares of Upwork ended the regular trading day down 0.5%.
-Claudia Assis
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-02-23 1649ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits